Position in ZLAB
as of Jun 30, 2026
· filed Sep 8, 2026
Position Value
$78,850
New position
Shares Held
4,150
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 92 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nykredit A/S holds $175,995,837 across 107 Biotechnology names. ZLAB ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
204,386 | $101,524,657 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,439 | $23,968,254 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,641 | $13,137,250 | |
| 4 | INSM |
INSMED Inc
|
90,852 | $9,686,640 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
44,928 | $8,414,115 | |
| 6 | INCY |
Incyte Corp
|
41,269 | $4,678,253 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
4,225 | $1,203,998 | |
| 8 | MRNA |
Moderna, Inc.
|
13,042 | $913,331 |
All Filings in ZLAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,850 | 4,150 | Shares | Defined | 2026-09-08 | |
| No filing history on record for this holder in this stock. | ||||||